Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit

Detalles Bibliográficos
Autor principal: Finsterer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688350/
https://www.ncbi.nlm.nih.gov/pubmed/34957384
http://dx.doi.org/10.1016/j.hest.2021.12.006
_version_ 1784618330756218880
author Finsterer, Josef
author_facet Finsterer, Josef
author_sort Finsterer, Josef
collection PubMed
description
format Online
Article
Text
id pubmed-8688350
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86883502021-12-21 Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit Finsterer, Josef Brain Hemorrhages Correspondence International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2022-03 2021-12-21 /pmc/articles/PMC8688350/ /pubmed/34957384 http://dx.doi.org/10.1016/j.hest.2021.12.006 Text en © 2021 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Finsterer, Josef
Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit
title Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit
title_full Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit
title_fullStr Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit
title_full_unstemmed Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit
title_short Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit
title_sort reply to the letter “venous sinus thrombosis after the second dose of sars-cov-2 vaccine administration” by mungmunpuntipantip and wiwanitkit
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688350/
https://www.ncbi.nlm.nih.gov/pubmed/34957384
http://dx.doi.org/10.1016/j.hest.2021.12.006
work_keys_str_mv AT finstererjosef replytothelettervenoussinusthrombosisaftertheseconddoseofsarscov2vaccineadministrationbymungmunpuntipantipandwiwanitkit

Ejemplares similares